Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2350]
News [4892]
Articles [202]
Editorials [8]
Conferences [136]
elearning [14]
Therapeutic targeting at a pre-metastatic stage for brain metastases from lung...
Dr Sheila Singh - McMaster University, Ontario, Canada
Therapeutic targeting at a pre-metastatic stage for brain metastases from lung cancer ( Dr Sheila Singh - McMaster University, Ontario, Canada )
22 Oct 2018
Neoadjuvant ipilimumab plus nivolumab in early stage colon cancer
Dr Myriam Chalabi - Netherlands Cancer Institute, Amsterdam, Netherlands
Neoadjuvant ipilimumab plus nivolumab in early stage colon cancer ( Dr Myriam Chalabi - Netherlands Cancer Institute, Amsterdam, Netherlands )
22 Oct 2018
KEYNOTE022: Triplet therapy for BRAF melanoma
Prof Paolo Ascierto - Istituto Nazionale Tumori - IRCCS "Fondazione G.Pascale"...
KEYNOTE022: Triplet therapy for BRAF melanoma ( Prof Paolo Ascierto - Istituto Nazionale Tumori - IRCCS "Fondazione G.Pascale", Milan, Italy )
22 Oct 2018
First-line pembrolizumab for recurrent/metastatic head and neck squamous cell...
Prof Barbara Burtness - Yale University School of Medicine and Yale Cancer...
First-line pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma ( Prof Barbara Burtness - Yale University School of Medicine and Yale Cancer Center New Haven, USA )
22 Oct 2018
ESMO 2018: Melanoma highlights
Dr Teresa Amaral, Will Davies
ESMO 2018: Melanoma highlights ( Dr Teresa Amaral, Will Davies )
22 Oct 2018
IMpower130: PFS and safety of adding atezolizumab to first-line NSCLC therapy
Dr Federico Cappuzzo - AUSL della Romagna-Ravenna, Ravenna, Italy
IMpower130: PFS and safety of adding atezolizumab to first-line NSCLC therapy ( Dr Federico Cappuzzo - AUSL della Romagna-Ravenna, Ravenna, Italy )
22 Oct 2018
KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck...
Prof Barbara Burtness - Yale Cancer Center, New Haven, USA
KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma ( Prof Barbara Burtness - Yale Cancer Center, New Haven, USA )
22 Oct 2018
ESMO 2018: Highlights
Prof Gordon McVie , Will Davies
ESMO 2018: Highlights ( Prof Gordon McVie , Will Davies )
22 Oct 2018
The TRIBE-2 study for colorectal cancer
Dr Chiara Cremolini - Università di Pisa, Pisa, Italy
The TRIBE-2 study for colorectal cancer ( Dr Chiara Cremolini - Università di Pisa, Pisa, Italy )
22 Oct 2018
Latest advances in precision medicine for prostate and bladder cancer
Prof Thomas Powles, Prof Matthew Galsky, Prof Bertrand Tombal
Latest advances in precision medicine for prostate and bladder cancer ( Prof Thomas Powles, Prof Matthew Galsky, Prof Bertrand Tombal )
22 Oct 2018
Advances in metastatic non small cell lung cancer
Dr Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany
Advances in metastatic non small cell lung cancer ( Dr Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )
21 Oct 2018
Comment on the JAVELIN study: RCC immunotherapy
Prof John Haanen - Netherlands Cancer Institute, Amsterdam, Netherlands
Comment on the JAVELIN study: RCC immunotherapy ( Prof John Haanen - Netherlands Cancer Institute, Amsterdam, Netherlands )
21 Oct 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation